Max van Wijk 🔬

Market access | Epidemiology | Infectious diseases & antimicrobial resistance | All views are my own

[Access to Medicine Foundation @AtMIndex]

NOW ONLINE: a new report zeroes in on what #pharma companies are doing to curb #AMR by manufacturing responsibly & identifies 3 key areas to boost companies' efforts.

Read the report 👉 https://t.co/E3ryZmepbq

#AntimicrobialResistance #StopSuperbugs #access2meds

[Max van Wijk 🔬 @max_vanwijk]

Mooi praktijkvoorbeeld van #doelmatigheid in de zorg uit België. / via @demorgen https://t.co/wzItuhUDqM

[Max van Wijk 🔬 @max_vanwijk]

Interesting talk by @JayasreeKIyer’s @AtMIndex earlier today at the World EPA Congress about healthcare inequity and the responsibility pharmaceutical companies should take in securing access to (essential) medicines across the globe. #EPAconf

[One Health Trust @OneHealthTrust]

Check out the latest policy brief from OHT and @WHO. We assessed the state of Mali’s national action plan on #AMR. We evaluated its implementation and worked to find ways to push progress in the human health sector.

Read here: https://t.co/7G6EPxZwyE

#Mali #Superbugs #FightAMR

[Max van Wijk 🔬 @max_vanwijk]

Happy to see that another review that I have contributed to has been published 🔖

This report, part of the #WHO series of policy brief on antimicrobial resistance (#AMR), focuses on the National Action Plan on AMR in #Mali.

You can find the report here: https://t.co/KPtHbUgwPn

[One Health Trust @OneHealthTrust]

NEW PUBLICATION! Check out the policy brief from OHT and the @WHO which assesses the present state of Kenya’s national action plan on antimicrobial resistance implementation and hurdles in the fight against #AMR.

Download the brief here: https://t.co/G4CmsSsbVV
#WAAW2022

[Max van Wijk 🔬 @max_vanwijk]

It was a pleasure to be talking today at @OUCRU_Programme's Careers in Science event as one of the invited speakers. Thanks for the invite @drleighannjones; I am sure that everyone left today's session inspired about a career in industry.

[Max van Wijk 🔬 @max_vanwijk]

Happy World #OneHealth day! 🐘

Recommended reading: the One Health Joint Plan of Action 2022-2026 that was published last month by the quadripartite organizations @FAO, @UNEP, @WHO, and @WOAH_Global.

📒Read here: https://t.co/7X9jW48Coq

[Max van Wijk 🔬 @max_vanwijk]

As a typical feature of cholera outbreaks, most of the current outbreaks are associated with displaced populations either following natural disaster (floods in Nigeria & Pakistan) or violence (Haiti, Somalian refugees in displacement camps in Kenya, and Syria).

[Max van Wijk 🔬 @max_vanwijk]

#Cholera outbreaks are ongoing in Syria, Haiti, Pakistan, Kenya, and Nigeria. This has led to such a high demand of #vaccines that the WHO has suspended the recommended 2-dose regimen and has switched to a single-shot regimen. A unique decision.

[One Health Trust @OneHealthTrust]

📣 New policy brief! As part of OHT's work as a WHO Collaborating Centre on Antimicrobial Resistance, OHT and @WHO researchers published on the implemention Malawi's of national action plan on AMR.

Read the brief here:
https://t.co/OfWVRPLdSF
#AMRinAfrica #AMR #SOSAMR #Superbugs

[Max van Wijk 🔬 @max_vanwijk]

Happy to share that I have contributed to this important series of policy briefs on antimicrobial resistance. The second one on #Malawi’s National Action Plane on #AMR is now published and can be found here: https://t.co/kCcX0Aqhhd

[Max van Wijk 🔬 @max_vanwijk]

Attending #ICPE22 in Copenhagen, Denmark. Looking forward to learning more about pharmacoepidemiology in the coming 5 days.

[Max van Wijk 🔬 @max_vanwijk]

And 6 more weeks full of fun activities and lectures to come 📚👨🏼‍🏫

[Soe Yu Naing @somaticsoe]

Second week of classes already, and this time I am teaching! It’s been very fun teaching the important topics of infectious diseases and one health together with @max_vanwijk at @ParamiUni

[Max van Wijk 🔬 @max_vanwijk]

Another great work by @somaticsoe and colleagues on two Acinetobacter baumannnii #outbreaks at a veterinary ICU. Interesting to read the significant, and commonly forgotten, value of whole genome sequencing on outbreak #epidemiology. Read more: https://t.co/ulA8iwZ1vD

[Max van Wijk 🔬 @max_vanwijk]

All 3 vaccines assessed did sufficiently protect against fatalities: "From July to October 2021, VE-D for age 65 years was 73.0% for Janssen, 81.5% for Moderna, and 84.3% for Pfizer-BioNTech".

[Max van Wijk 🔬 @max_vanwijk]

Recent Science report shows a dramatic decline in vaccine effectiveness among 780,225 US veterans. The protective effect of J&J against infection even declined to a worrying 13% within 6 months. Time for a #booster for J&J recipients?

https://t.co/SdXbmGK9y0

[Max van Wijk 🔬 @max_vanwijk]

"From February to October 2021, VE-I (vaccine effectiveness against infection) declined from 87.9% to 48.1%, and the decline was greatest for the Janssen vaccine resulting in a VE-I of 13.1%".

[Max van Wijk 🔬 @max_vanwijk]

My very first first-author paper got published last year in @PLOSONE. Climate change and infectious diseases are intertwined and many people are unfortunately not aware of this. Hope that #COP26 is aware of the effect of #ClimateChange on #PublicHealth.

https://t.co/kKbOmRojLB

[Max van Wijk 🔬 @max_vanwijk]

Exactly two weeks ago, I successfully defended my thesis on #AMR carriage in rural #Vietnam conducted at @OUCRU_Vietnam

This marked the end of my @EUErasmusPlus, and I am now officially #graduated as a MSc in Infectious Diseases and One Health🎓